The Technion-Israel Institute of Technology has developed a potential nanomedicine treatment for stomach cancer, using a combination of anti-cancer drugs and a chemo-resistance reversal agent that eliminates gastric tumors’ resistance to chemotherapy drugs. The treatment could be self-administered at home by the patient—eliminating the need for hospitalization, which is dangerous for...
Continue Reading >>










